IRIS
SANGUEDOLCE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.973
EU - Europa 5.171
AS - Asia 4.146
SA - Sud America 750
Continente sconosciuto - Info sul continente non disponibili 636
AF - Africa 79
OC - Oceania 13
Totale 17.768
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.797
SG - Singapore 1.569
IE - Irlanda 1.390
CN - Cina 1.106
RU - Federazione Russa 910
HK - Hong Kong 677
SE - Svezia 652
BR - Brasile 595
IT - Italia 568
UA - Ucraina 539
FR - Francia 343
VN - Vietnam 266
DE - Germania 248
IN - India 147
GB - Regno Unito 135
FI - Finlandia 130
BD - Bangladesh 83
TR - Turchia 77
CA - Canada 75
ID - Indonesia 59
AR - Argentina 58
MX - Messico 46
CZ - Repubblica Ceca 40
NL - Olanda 36
PL - Polonia 36
IQ - Iraq 29
ZA - Sudafrica 28
ES - Italia 25
AT - Austria 23
VE - Venezuela 22
EC - Ecuador 20
BE - Belgio 19
JP - Giappone 17
CL - Cile 14
CR - Costa Rica 14
AU - Australia 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
LT - Lituania 12
PY - Paraguay 12
CO - Colombia 11
EU - Europa 11
GR - Grecia 11
KE - Kenya 11
PE - Perù 11
PK - Pakistan 11
SA - Arabia Saudita 11
EG - Egitto 9
JO - Giordania 8
MA - Marocco 8
BA - Bosnia-Erzegovina 7
AZ - Azerbaigian 6
CH - Svizzera 6
DO - Repubblica Dominicana 6
IL - Israele 6
JM - Giamaica 6
LB - Libano 6
LV - Lettonia 6
AM - Armenia 5
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
HN - Honduras 5
IR - Iran 5
TT - Trinidad e Tobago 5
AL - Albania 4
GT - Guatemala 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NO - Norvegia 4
RO - Romania 4
BG - Bulgaria 3
BO - Bolivia 3
NI - Nicaragua 3
NP - Nepal 3
PH - Filippine 3
TN - Tunisia 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
CG - Congo 2
CI - Costa d'Avorio 2
GE - Georgia 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
MG - Madagascar 2
MK - Macedonia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
Totale 17.131
Salva come PNG Salva come JPEG
Città #
San Jose 1.479
Dublin 1.389
Singapore 749
Hong Kong 677
Ashburn 581
Chandler 487
Nyköping 481
Jacksonville 366
Dallas 272
Santa Clara 261
Beijing 235
Council Bluffs 231
New York 225
Dearborn 222
Columbus 192
Lauterbourg 172
Nanjing 168
Princeton 143
Moscow 141
Munich 113
The Dalles 102
Wilmington 92
Ho Chi Minh City 86
Los Angeles 85
Nanchang 78
Helsinki 68
São Paulo 62
Shenyang 53
San Mateo 52
Rome 50
Hanoi 49
Phoenix 49
Bari 47
Milan 46
Ann Arbor 40
Boardman 39
Seattle 30
Tianjin 28
Warsaw 28
Foggia 27
Hebei 27
Brooklyn 25
Frankfurt am Main 25
London 25
Brno 24
Chicago 24
Jiaxing 24
Shanghai 24
Kunming 23
Nuremberg 23
Pune 23
Jinan 22
Rio de Janeiro 22
Guangzhou 21
Hangzhou 20
New Providence 20
Changsha 19
Des Moines 19
Hudson 19
Montreal 19
Naples 19
San Francisco 19
Turku 19
Brussels 18
Belo Horizonte 17
Orem 16
Agrolândia 15
Chennai 15
Tokyo 15
Haiphong 14
San José 14
Brasília 13
Mexico City 13
Olomouc 13
Washington 13
Denver 12
Falkenstein 12
Tashkent 12
Toronto 12
Vienna 12
Baghdad 11
Da Nang 11
Hillsboro 11
Johannesburg 11
Reading 11
Zhengzhou 11
Boston 10
Düsseldorf 10
Jakarta 10
Taizhou 10
Atlanta 9
Guayaquil 9
Ningbo 9
Norwalk 9
Porto Alegre 9
Thái Nguyên 9
Assago 8
Borås 8
Chengdu 8
Lima 8
Totale 10.628
Salva come PNG Salva come JPEG
Nome #
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 231
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 231
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 208
A recurrent epidermoid cyst of the spleen: report of a case and literature review 187
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 178
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 172
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 167
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 165
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 160
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 158
Un caso di sarcoma di Kaposi viscerale in un paziente con morbo di crohn duodenale e immunodeficienza congenita. 156
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 154
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 151
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 151
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 148
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 148
Surgicel (R) granuloma mimicking ovarian cancer: A case report 145
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 145
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 143
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 142
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 141
One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report 140
Can inspection of the mouth help clinicians diagnose Crohn's disease? A review 139
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 137
Asymptomatic solitary bladder plasmocytoma: A case report and literature review 137
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 137
Role of age in prostate and bladder cancer. A critical overview 135
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 134
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation 134
Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review 133
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 133
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 131
Hemoperitoneum due to breaking uterine adenosarcoma located in the omentum. Report of a case 129
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 128
An unusual delayed complication of paraffin self-injection for penile girth augmentation. 128
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 127
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 124
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 120
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 120
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 119
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 119
Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre series 117
ARE WE DOING OUR BEST TO PREVENT THE (UNEXPECTED) DISAPPOINTING SIDE EFFECTS OF AN OTHERWISE SUCCESSFUL CANCER TREATMENT? 117
Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment 117
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 116
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 116
Surgicel® granuloma mimicking ovarian cancer: A case report 116
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 116
Daily tadalafil for the chronic phase of stuttering priapism: A case report 114
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 113
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 112
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 111
Epidermoid cyst of the coronal sulcus mimicking penile cancer: a case report. 111
Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm 111
Ectopic manifestation of a cholesterol granuloma in the nasopalatine duct 111
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy 111
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 109
p-NFkB expression in thyroid cancer. 108
Magnetic resonance imaging of penile paraffinoma: Case report 106
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 106
Asymptomatic bladder metastasis from breast cancer. 104
Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use? 104
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 103
Molecular markers in bladder cancer: Novel research frontiers 103
Modulation of complement activation by pentraxin-3 in prostate cancer 103
Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. 103
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 103
N-cadherin up-regulation in aggressive oral squamous cell carcinoma. 102
Prostate cancer biomarkers: a practical review based on different clinical scenarios 102
Pilonidal cyst of the penis mimicking carcinoma. 101
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 101
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 98
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 98
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 97
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 97
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  97
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications 97
The complex relationship between upper urinary tract and bladder cancer: Clinical and predictive issues 96
Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets 96
Elderly patients and prostate biopsy. How old is too old? 96
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 95
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience 95
Liquid Biopsy as a New Tool for Diagnosis and Monitoring in Renal Cell Carcinoma 94
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report 94
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 93
Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell-renal cell carcinoma 92
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study 92
Urinary tract large cell neuroendocrine carcinoma: Diagnostic, prognostic and therapeutic issues 91
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 90
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 90
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 89
Micropapillary bladder cancer, a variant histology of the elderly 88
Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update 87
Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma. 86
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 85
Assessing PD-L1 Expression in Different Tumor Types 84
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 84
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables 84
PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives 83
Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation 81
Totale 12.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.609
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022697 0 0 0 12 45 9 93 60 101 150 27 200
2022/20233.001 262 181 146 107 144 230 10 222 1.532 44 55 68
2023/2024823 83 37 36 20 40 283 72 38 10 23 41 140
2024/20253.205 151 51 131 62 95 360 311 141 795 457 306 345
2025/20265.628 365 442 647 745 298 233 1.121 641 365 400 164 207
2026/20271.716 132 472 468 644 0 0 0 0 0 0 0 0
Totale 17.768